Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Advanced measurable or non-measurable solid tumors
Adequate bone marrow function
Adequate liver function
Adequate renal function
Be able and willing to comply with the study scheduled visits, treatment plans, laboratory tests and other procedures
You may not be if
Chemotherapy, radiotherapy, or any investigational cancer therapy within 4 weeks of first dose of study medication
Active bleeding disorder, including gastrointestinal bleeding, as evidenced by hematemesis, hemoptysis or melena in the past 6 months
Any of the following within the 12 months prior to starting study treatment: myocardial infarction, severe/unstable angina, coronary/peripheral artery bypass graft, congestive heart failure, cerebrovascular accident including transient ischemic attack, or pulmonary embolus; or any other active thromboembolic event
QTc prolongation defined as QTc \>450 msec
Patients with known brain metastasis
Patients with peritoneal carcinosis at risk of bleeding
Major surgical procedure within 4 weeks of treatment
